Rekrutierung

Eingeschlossene Patienten: 19.153 (Stand 06. Januar 2020)
Amgevita® (Adalimumab)	55
Benepali® (Etanercept)	646
Cimzia® (Certolizumab)	902
Enbrel® (Etanercept)	2859
Erelzi® (Etanercept)	224
Flixabi® (Infliximab)	3
Hulio® (Adalimumab)	13
Humira® (Adalimumab)	2905
Hyrimoz® (Adalimumab)	47
Idacio® (Adalimumab)	2
Imraldi® (Adalimumab)	60
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	112
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Olumiant® (Baricitinib)	349
Orencia® (Abatacept)	804
Remicade® (Infliximab)	762
Remsima® (Infliximab)	11
Rixathon® (Rituximab)	9
RoActemra® (Tocilizumab)	1324
Simponi® (Golimumab)	444
Xeljanz® (Tofacitinib)	269
Zessly® (Infliximab)	2
Kontrollen	5787